We also compared endocan and E-selectin (Luminex analyses, the 89 first consecutive patients) plasma levels for patients with and without deep vein thrombosis, but none of the two biomarkers differed significantly (p = 0.18 and p = 0.19, respectively). Here, SELE is linked to deep vein thrombosis.